½ÃÀ庸°í¼­
»óǰÄÚµå
1708914

Áö¹æ ¾Æ¹Ìµå ½ÃÀå : Á¦Ç° À¯Çüº°, Çüź°, Áö¿ªº°

Fatty Amides Market, By Product Type (Erucamide, Oleamide, Stearamide, Behenamide), By Form (Powder, Beads, Micro-beads, Pastilles), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Coherent Market Insights | ÆäÀÌÁö Á¤º¸: ¿µ¹® | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

Áö¹æ ¾Æ¹Ìµå ¼¼°è ½ÃÀåÀº 2025³â¿¡´Â 4¾ï 2,860¸¸ ´Þ·¯·Î ÃßÁ¤µÇ¸ç 2032³â¿¡´Â 5¾ï 7,550¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, 2025-2032³â 4.3%ÀÇ CAGR·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

º¸°í¼­ ¹üÀ§ º¸°í¼­ »ó¼¼
±âÁØ ¿¬µµ 2024³â 2025³â ½ÃÀå ±Ô¸ð 4¾ï 2,860¸¸ ´Þ·¯
½ÇÀû µ¥ÀÌÅÍ 2020-2024³â ¿¹Ãø ±â°£ 2025-2032³â
¿¹Ãø ±â°£ : 2025-2032³â CAGR 4.30% 2032³â ±Ý¾× ¿¹Ãø 5¾ï 7,550¸¸ ´Þ·¯
±×¸². Áö¹æ ¾Æ¹Ìµå ½ÃÀå Á¡À¯À²(%), Áö¿ªº°, 2025³â
Fatty Amides Market-IMG1

¼¼°è Áö¹æ ¾Æ¹Ìµå ½ÃÀåÀº ÇÃ¶ó½ºÆ½, °í¹«, ÆäÀÎÆ® µî ´Ù¾çÇÑ ÃÖÁ¾ ÀÌ¿ë »ê¾÷¿¡¼­ÀÇ ¿ëµµ È®´ë·Î ÀÎÇØ ÃÖ±Ù ¸î ³â µ¿¾È °ý¸ñÇÒ¸¸ÇÑ ¼ºÀå¼¼¸¦ º¸À̰í ÀÖ½À´Ï´Ù. Áö¹æ ¾Æ¹Ìµå´Â ÁÖ·Î ÀÌµé »ê¾÷¿¡¼­ À±È°Á¦, À¯µ¿ ÃËÁøÁ¦, °³È­ ¹æÁöÁ¦·Î »ç¿ëµË´Ï´Ù. Áö¹æ ¾Æ¹Ìµå´Â ¿ì¼öÇÑ ¿­ ¾ÈÁ¤¼º, ³»È­Çмº, ³ÐÀº ¾×»ó ¹üÀ§¿Í °°Àº ¿ì¼öÇÑ Æ¯¼ºÀ» °¡Áö°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, Àç»ý °¡´ÉÇÑ µ¿½Ä¹° À¯·¡ÀÇ Áö¹æ ¾Æ¹Ìµå´Â ¼®À¯ À¯·¡ Á¦Ç°¿¡ ´ëÇÑ ÀÇÁ¸µµ¸¦ ³·Ãß´Â µ¥ µµ¿òÀÌ µÇ¾î ½ÃÀå ¼ºÀåÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ±×·¯³ª ¿ø·á °¡°ÝÀÇ º¯µ¿Àº ¿©ÀüÈ÷ Áß¿äÇÑ °úÁ¦ÀÔ´Ï´Ù. ±×·¯³ª ¹ÙÀÌ¿À ±â¹Ý È­ÇÐÁ¦Ç°ÀÇ Áö¼Ó°¡´É¼º°ú ÀÌÁ¡¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁü¿¡ µû¶ó Áö¹æ ¾Æ¹Ìµå Á¦Á¶¾÷üÀÇ ºñÁî´Ï½º ±âȸ°¡ È®´ëµÇ°í ÀÖ½À´Ï´Ù. Áö¹æ ¾Æ¹Ìµå´Â Á¾Á¾ Áö¹æ»ê ¾Æ¹Ìµå¶ó°í ºÒ¸®¸ç OH ±×·ìÀÌ NH2(¾Æ¹Î) ±×·ìÀ¸·Î ´ëü µÈ À¯±â Áö¹æ»êÀÇ À¯µµÃ¼ÀÔ´Ï´Ù. Á¦Ç°ÀÇ Á¾·ù¿¡ µû¶ó Áö¹æ ¾Æ¹Ìµå´Â ¿¤Ä«¹Ìµå, ¿Ã·¹Àξƹ̵å, ½ºÅ׾ƶó¹Ìµå, º£Ç쳪¹Ìµå·Î ±¸ºÐµË´Ï´Ù. Áö¹æ ¾Æ¹Ìµå¸¦ ÇÔÀ¯ÇÑ Á¦Ç°Àº ºñµå ÇüÅÂ, ºÐ¸» ÇüÅÂ, °æ¿ì¿¡ µû¶ó¼­´Â ÆÄ½ºÆ¿ ÇüÅ·ΠÆÇ¸ÅµË´Ï´Ù.

½ÃÀå ¿ªÇÐ

ÇÃ¶ó½ºÆ½ °í¹« »ê¾÷ÀÇ ¼ºÀå¿¡ µû¸¥ ¼ö¿ä Áõ°¡¿Í ¹ÙÀÌ¿À ±â¹Ý È­ÇÐÁ¦Ç°ÀÇ º¸±ÞÀÌ ¼¼°è Áö¹æ ¾Æ¹Ìµå ½ÃÀåÀÇ ¼ºÀåÀ» ÁÖµµÇϰí ÀÖ½À´Ï´Ù. Áö¹æ ¾Æ¹Ìµå´Â ÇÃ¶ó½ºÆ½ ¹× °í¹« ¹èÇÕ¿¡¼­ À±È°Á¦, ÀÌÇüÁ¦, ¾ÈƼºí·ÎÅ·Á¦·Î¼­ ÁÖ¿ä ¿ëµµ¸¦ ¹ß°ßÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, °í¼º´É Á¦Ç°¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÔ¿¡ µû¶ó Áö¹æ ¾Æ¹ÌµåÀÇ ¼Òºñ°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ±×·¯³ª ÆÊÀ¯, ¾ßÀÚÀ¯, Åç·ç¿£À¯ µî ¿ø·áÀÇ °¡°Ý º¯µ¿°ú ºÒ¾ÈÁ¤ÇÑ °ø±ÞÀÌ Å« ¹®Á¦Á¡À¸·Î ÁöÀûµÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¼®À¯È­ÇÐ ±â¹Ý Á¦Ç°ÀÇ ¹èÃâ¿¡ ´ëÇÑ ¾ö°ÝÇÑ È¯°æ ±ÔÁ¦°¡ ½ÃÀå ¼ºÀåÀ» ÀúÇØÇϰí ÀÖ½À´Ï´Ù. ¹Ý¸é, Áö¼Ó°¡´É¼º°ú ¹ÙÀÌ¿À ±â¹Ý È­ÇÐÁ¦Ç°¿¡ ´ëÇÑ ¼±È£µµ º¯È­´Â Å« ±âȸ¸¦ Á¦°øÇÕ´Ï´Ù. ÁÖ¿ä ±â¾÷µéÀº »õ·Î¿î ÀÀ¿ë ºÐ¾ß¿Í ģȯ°æ »ý»ê ±â¼úÀ» °³¹ßÇϱâ À§ÇØ ¿¬±¸°³¹ß¿¡ ÅõÀÚÇϰí ÀÖ½À´Ï´Ù.

º» Á¶»çÀÇ ÁÖ¿ä Æ¯Â¡

  • ¼¼°èÀÇ Áö¹æ ¾Æ¹Ìµå ½ÃÀåÀ» »ó¼¼È÷ ºÐ¼®ÇÏ¿© 2024³âÀ» ±âÁØ ¿¬µµ·Î ÇÏ¿© ¿¹Ãø ±â°£(2025-2032³â)ÀÇ ½ÃÀå ±Ô¸ð¿Í ¿¬Æò±Õ ¼ºÀå·ü(CAGR)À» Á¶»ç ºÐ¼®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù.
  • ¶ÇÇÑ, ´Ù¾çÇÑ ºÎ¹®¿¡ °ÉÄ£ ÀáÀçÀûÀÎ ¼öÀÍ ¼ºÀå ±âȸ¸¦ ¹àÈ÷°í, ÀÌ ½ÃÀåÀÇ ¸Å·ÂÀûÀÎ ÅõÀÚ Á¦¾È ¸ÅÆ®¸¯½º¸¦ ¼³¸íÇÕ´Ï´Ù.
  • ¶ÇÇÑ ½ÃÀå ÃËÁø¿äÀÎ, ¾ïÁ¦¿äÀÎ, ±âȸ, ½ÅÁ¦Ç° Ãâ½Ã ¹× ½ÂÀÎ, ½ÃÀå µ¿Çâ, Áö¿ªº° Àü¸Á, ÁÖ¿ä ±â¾÷ÀÇ °æÀï Àü·« µî¿¡ ´ëÇÑ Áß¿äÇÑ ÀλçÀÌÆ®¸¦ Á¦°øÇÕ´Ï´Ù.
  • ÀÌ º¸°í¼­´Â ȸ»ç ÇÏÀ̶óÀÌÆ®, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÁÖ¿ä ÇÏÀ̶óÀÌÆ®, À繫 ¼º°ú, Àü·« µîÀÇ ¸Å°³ º¯¼ö¸¦ ±â¹ÝÀ¸·Î Áö¹æ ¾Æ¹Ìµå ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷À» ÇÁ·ÎÆÄÀϸµÇÕ´Ï´Ù.
  • ÀÌ º¸°í¼­ÀÇ ÀλçÀÌÆ®¸¦ ÅëÇØ ¸¶ÄÉÆÃ ´ã´çÀÚ¿Í ±â¾÷ °æ¿µÁøÀº ÇâÈÄ Á¦Ç° Ãâ½Ã, À¯ÇüÈ­, ½ÃÀå È®´ë, ¸¶ÄÉÆÃ Àü¼ú¿¡ ´ëÇÑ Á¤º¸¿¡ ÀÔ°¢ÇÑ ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖ½À´Ï´Ù.
  • Áö¹æ ¾Æ¹Ìµå ½ÃÀå º¸°í¼­´Â ÅõÀÚÀÚ, °ø±Þ¾÷ü, Á¦Ç° Á¦Á¶¾÷ü, À¯Åë ¾÷ü, À¯Åë ¾÷ü, ½Å±Ô Âü°¡ÀÚ, À繫 ºÐ¼®°¡ µî ÀÌ »ê¾÷ÀÇ ´Ù¾çÇÑ ÀÌÇØ °ü°èÀÚ¸¦ ´ë»óÀ¸·Î ÇÕ´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¸ñÀû°ú °¡Á¤

  • Á¶»ç ¸ñÀû
  • °¡Á¤
  • ¾à¾î

Á¦2Àå ½ÃÀå Àü¸Á

  • º¸°í¼­ ¼³¸í
    • ½ÃÀå Á¤ÀÇ¿Í ¹üÀ§
  • ÁÖ¿ä ¿ä¾à
  • Coherent Opportunity Map(COM)

Á¦3Àå ½ÃÀå ¿ªÇÐ, ±ÔÁ¦, µ¿Ç⠺м®

  • ½ÃÀå ¿ªÇÐ
  • ÆÛ½º³ÎÄÉ¾î »ê¾÷À¸·ÎºÎÅÍÀÇ ¼ö¿ä Áõ°¡
  • ´ëüǰÀÇ ÀÔ¼ö °¡´É¼º
  • Æ´»õ ÇüÅ À» À§ÇÑ Áö¹æÁ· ¾Æ¹Ìµå Çõ½Å
  • ±ÔÁ¦ ½Ã³ª¸®¿À
  • Á¦Ç° ¹ß¸Å/½ÂÀÎ
  • PEST ºÐ¼®
  • Porters ºÐ¼®
  • ÇÕº´, Àμö, Á¦ÈÞ

Á¦4Àå Áö¹æ»ê ¾Æ¹Ìµå ½ÃÀå - Äڷγª¹ÙÀÌ·¯½º(COVID-19) ÆÒµ¥¹ÍÀÇ ¿µÇâ

  • COVID-19 ¿ªÇÐ
  • °ø±ÞÃø°ú ¼ö¿äÃø ºÐ¼®
  • °æÁ¦¿¡ ´ëÇÑ ¿µÇâ

Á¦5Àå Áö¹æÁ· ¾Æ¹Ìµå ½ÃÀå, Á¦Ç° À¯Çüº°, 2020-2032³â

  • ¼Ò°³
  • ¿¡·çÄ«¸¶À̵å
  • ¿Ã·¹¾Æ¹Ìµå
  • ½ºÅ׾ƶó¹Ìµå
  • º£Ç쳪¹Ìµå

Á¦6Àå Áö¹æ»ê ¾Æ¹Ìµå ½ÃÀå, Çüź°, 2020-2032³â

  • ¼Ò°³
  • ºÐ¸»¡¤ºñÁî
  • ¸¶ÀÌÅ©·Î ºñÁî
  • ÆÄ½ºÆ¼¸£

Á¦7Àå Áö¹æ»ê ¾Æ¹Ìµå ½ÃÀå, Áö¿ªº°, 2020-2032³â

Á¦8Àå °æÀï ±¸µµ

  • ±â¾÷ °³¿ä
    • Lonza
    • Novartis International AG
    • BASF AG
    • SEQENS
    • Carbogen Amcis AG
    • Eli Lilly and Company
    • Teva Pharmaceutical Industries Ltd
    • Bristol-Myers Squibb
    • Pfizer Inc.
    • Roche Diagnostics
    • Boehringer Ingelheim
    • Merck & Co
    • Bayer AG
    • Ajinomoto Bio-Pharma Services
    • Cambrex Corporation
    • Minakem
    • Sanofi Aventis

Á¦9Àå ¼½¼Ç

  • Âü°í¹®Çå
  • Á¶»ç ¹æ¹ý
  • ÃâÆÇ»ç ¼Ò°³
ksm 25.05.30

Global Fatty Amides Market is estimated to be valued at USD 428.6 Mn in 2025 and is expected to reach USD 575.5 Mn by 2032, growing at a compound annual growth rate (CAGR) of 4.3% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 428.6 Mn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 4.30% 2032 Value Projection: USD 575.5 Mn
Figure. Fatty Amides Market Share (%), By Region 2025
Fatty Amides Market - IMG1

The global fatty amides market has been witnessing significant growth in recent years driven by growing applications in various end-use industries such as plastics, rubber, coatings, and others. Fatty amides are mainly used as lubricants, flow promoters, and anti-blooming agents in these industries. They offer excellent properties such as outstanding thermal stability, chemical resistance, and wide liquid range. Additionally, fatty amides derived from renewable plant and animal sources help reduce dependency on petroleum-based products, thereby boosting the market growth. However, fluctuations in raw material prices remain a key challenge. But growing awareness about sustainability and benefits of bio-based chemicals is expanding opportunities for fatty amides manufacturers. Fatty amides, often termed fatty acid amides, are derivatives of organic fatty acids where an OH group is replaced by an NH2 (amine) group. Depending on the type of product, fatty amides are differentiated as erucamides, oleamides, stearamides, and behenamides. Products containing fatty amides are available in beads, powders, and sometimes also the pastilles form.

Market Dynamics:

The growth of the global fatty amides market is driven by factors such as increasing the demand from the thriving plastics and rubber industries and widespread adoption of bio-based chemicals. Fatty amides find major applications as lubricants, release agents, and anti-blocking agents in plastics and rubber formulations. Additionally, the growing need for high-performance products is propelling the consumption of fatty amides. However, fluctuations in prices and unreliable supply of raw materials such as palm oil, coconut oil, and tall oil pose a major challenge. Furthermore, strict environmental regulations regarding emissions from petrochemical-based products restrain the market growth. Meanwhile, shifting preference toward sustainability and bio-based chemicals presents significant opportunities. Leading players are investing in R&D to develop novel application areas and green production technologies.

Key Features of the Study:

  • This report provides an in-depth analysis of the fatty amides market, and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2025-2032), considering 2024 as the base year
  • It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the fatty amides market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Haihang Industries Co. Ltd., Croda International Plc., PMC Biogenix Inc., Fine Organic Industries Pvt. Ltd., Nippon Fine Chemicals Co., Ltd., Kao Corporation, Italmatch Chemicals S.p.A., Sichuan Tianyu Oleochemical Co., Ltd., and Nippon Kasei Chemical Co., Ltd.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The fatty amides market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Detailed Segmentation:

  • Fatty Amides Market, By Product Type
    • Erucamides
    • Oleamides
    • Stearamides
    • Behenamides
  • Fatty Amides Market, By Form
    • Powder, Beads
    • Micro-beads
    • Pastilles
  • Fatty Amides Market, By Region
    • North America
    • Latin America
    • Europe
    • Asia Pacific
    • Middle East
    • Africa
  • Company Profiles
    • Haihang Industries Co. Ltd.
    • Croda International Plc.
    • PMC Biogenix Inc.
    • Fine Organic Industries Pvt. Ltd.
    • Nippon Fine Chemicals Co., Ltd.
    • Kao Corporation
    • Italmatch Chemicals S.p.A.
    • Sichuan Tianyu Oleochemical Co., Ltd.
    • Nippon Kasei Chemical Co., Ltd

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Fatty Amides Market, By Product Type
    • Fatty Amides Market, By Form
    • Fatty Amides Market, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
  • Increasing demand from the personal care industry
    • Restraints
  • Availability of substitutes
    • Opportunities
  • Innovation of fatty amides for niche Forms
  • Key Highlights
  • Regulatory Scenario
  • Recent Trends
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Mergers, Acquisitions, and Collaborations

4. Fatty Amides Market- Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Fatty Amides Market, By Product Type, 2020-2032, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Erucamide
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Stearamide
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Behenamide
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Oleamide
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

6. Fatty Amides Market, By Form , 2020-2032, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Powder, Beads
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Micro-beads
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Pastilles
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

7. Fatty Amides Market , By Region, 2020-2032, (US$ Mn)

  • Introduction
    • Market Share Analysis, By Region, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, For Region, 2021 - 2032
    • Country Trends
    • North America
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Product Type , 2020-2032,(US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Form, 2020-2032,(US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
        • U.S.
        • Canada
    • Europe
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Product Type , 2020-2032,(US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Form, 2020-2032,(US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
        • Germany
        • U.K.
        • Spain
        • France
        • Italy
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Product Type , 2020-2032,(US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Form, 2020-2032,(US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Latin America
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Product Type , 2020-2032,(US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Form, 2020-2032,(US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
        • Brazil
        • Argentina
        • Mexico
        • Rest of Latin America
    • Middle East & Africa
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Product Type , 2020-2032,(US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Form, 2020-2032,(US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
        • GCC Countries
        • Israel
        • Rest of Middle East
        • South Africa
        • Central Africa
        • North Africa

8. Competitive Landscape

  • Company Profile
    • Lonza
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Novartis International AG
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • BASF AG
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • SEQENS
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Carbogen Amcis AG
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Eli Lilly and Company
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Teva Pharmaceutical Industries Ltd
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Bristol-Myers Squibb
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Pfizer Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Roche Diagnostics
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Boehringer Ingelheim
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Merck & Co
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Bayer AG
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Ajinomoto Bio-Pharma Services
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Cambrex Corporation
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Minakem
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Sanofi Aventis
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
      • Analyst Views

9. Section

  • References
  • Research Methodology
  • About us
»ùÇà ¿äû ¸ñ·Ï
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
¸ñ·Ï º¸±â
Àüü»èÁ¦